ArticleRadiology. Artificial intelligence2022
Longitudinal Assessment of Posttreatment Diffuse Glioma Tissue Volumes with Three-dimensional Convolutional Neural Networks.
Article in Radiology. Artificial intelligence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Automated longitudinal treatment response assessment of brain tumors: A systematic review.Neuro-oncology · 2025Pooled it
- A Systematic Review on the Use of Registration-Based Change Tracking Methods in Longitudinal Radiological Images.Journal of imaging informatics in medicine · 2025Pooled it
- The University of California San Diego Post-Treatment Glioblastoma (UCSD-PTGBM) annotated multimodal MRI Dataset.Scientific data · 2026Article
- Applications of artificial intelligence and advanced imaging in pediatric diffuse midline glioma.Neuro-oncology · 2025Review
- Development and Evaluation of Automated Artificial Intelligence-Based Brain Tumor Response Assessment in Patients with Glioblastoma.AJNR. American journal of neuroradiology · 2025Article
- A critical assessment of artificial intelligence in magnetic resonance imaging of cancer.Npj imaging · 2025Review
- The University of California San Francisco Adult Longitudinal Post-Treatment Diffuse Glioma MRI Dataset.Radiology. Artificial intelligence · 2024Article
- Automated segmentation of ablated lesions using deep convolutional neural networks: A basis for response assessment following laser interstitial thermal therapy.Neuro-oncology · 2024Article
- Improving the Generalizability of Deep Learning for T2-Lesion Segmentation of Gliomas in the Post-Treatment Setting.Bioengineering (Basel, Switzerland) · 2024Article
- Human-Level Differentiation of Medulloblastoma from Pilocytic Astrocytoma: A Real-World Multicenter Pilot Study.Cancers · 2024Article
- Multimodal Machine Learning in Image-Based and Clinical Biomedicine: Survey and Prospects.International journal of computer vision · 2024Article
- Towards Longitudinal Glioma Segmentation: Evaluating combined pre- and post-treatment MRI training data for automated tumor segmentation using nnU-Net.medRxiv : the preprint server for health sciences · 2023Article
- Independent Validation of a Deep Learning nnU-Net Tool for Neuroblastoma Detection and Segmentation in MR Images.Cancers · 2023Article
- 3D U-Net for automated detection of multiple sclerosis lesions: utility of transfer learning from other pathologies.Frontiers in neuroscience · 2023Article
- Segmentation of pre- and posttreatment diffuse glioma tissue subregions including resection cavities.Neuro-oncology advancesArticle
- Comparison of volumetric and 2D-based response methods in the PNOC-001 pediatric low-grade glioma clinical trial.Neuro-oncology advancesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Neural networks were trained for segmentation and longitudinal assessment of posttreatment diffuse glioma. A retrospective cohort (from January 2018 to December 2019) of 298 patients with diffuse glioma (mean age, 52 years ± 14 [SD]; 177 men; 152 patients with glioblastoma, 72 patients with astrocytoma, and 74 patients with oligodendroglioma) who underwent two consecutive multimodal MRI examinations were randomly selected into training (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.